Veterinary Medicines

COVEXIN 8A ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Not authorised
  • Immunoglobulins against Clostridium tetani toxin, Equine
  • Clostridium septicum, toxoid
  • Clostridium novyi, Inactivated
  • Clostridium chauvoei, Inactivated
  • Clostridium perfringens, serotype D, Inactivated
  • Clostridium perfringens, serotype C, Inactivated
  • Clostridium perfringens, serotype A, Inactivated
Download as PDF

Product identification

Medicine name:
COVEXIN 8A ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Immunoglobulins against Clostridium tetani toxin, Equine
  • Clostridium septicum, toxoid
  • Clostridium novyi, Inactivated
  • Clostridium chauvoei, Inactivated
  • Clostridium perfringens, serotype D, Inactivated
  • Clostridium perfringens, serotype C, Inactivated
  • Clostridium perfringens, serotype A, Inactivated
Target species:
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Immunoglobulins against Clostridium tetani toxin, Equine
    1.20
    unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium novyi, Inactivated
    2.10
    unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    0.30
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, serotype D, Inactivated
    3.00
    unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, serotype C, Inactivated
    4.60
    unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, serotype A, Inactivated
    0.80
    unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal, milk
        0
        day
    • Goat
      • Meat and offal, milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 23774/02-09-1988/K-0008801
Date of authorisation status change: